Who is sponsoring NCT04350645?

NCT04350645 is sponsored by Universiti Kebangsaan Malaysia Medical Centre.

What drugs are being tested in NCT04350645?

Interventions in NCT04350645: Tranexamic acid injection, Normal Saline 0.9%.

What condition does NCT04350645 study?

NCT04350645 studies Hemorrhage From Placenta Previa, With Delivery.

Is NCT04350645 still recruiting?

NCT04350645 is currently status unknown. Last updated 12 January 2021.

Last reviewed 2021-01-12 · How we verify

NCT04350645

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Role of Prophylactic Tranexamic Acid in Reducing Blood Loss During Elective Caesarean Section for Placenta Praevia Major

Status unknown NA Last updated 12 January 2021

What this trial tests

NA trial testing Tranexamic acid injection in Hemorrhage From Placenta Previa, With Delivery in 30 participants. Status unknown.

Timeline

24 March 2020

Primary endpoint
23 December 2021

23 December 2021

Quick facts

Lead sponsor	Universiti Kebangsaan Malaysia Medical Centre
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	prevention
Enrollment	30
Start date	24 March 2020
Primary completion	23 December 2021
Estimated completion	23 December 2021
Sites	1 location across Malaysia

Drugs / interventions tested

Tranexamic acid injection — full drug profile →
Normal Saline 0.9% — full drug profile →

Conditions studied

Hemorrhage From Placenta Previa, With Delivery — all drugs for Hemorrhage From Placenta Previa, With Delivery →

Sponsor

Universiti Kebangsaan Malaysia Medical Centre — full company profile →

Who can join

Adults 18 to 45, female only, with Hemorrhage From Placenta Previa, With Delivery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prophylactic tranexamic acid will reduce blood loss during Caesarean section for placenta praevia

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine.
Vlaar APJ, Dionne JC, de Bruin S, Wijnberge M, et al · · 2021 · cited 65× · PMID 34677620 · DOI 10.1007/s00134-021-06531-x

Verify or expand the search:

Other trials of Tranexamic acid injection

Trials testing the same drug.

NCT04387305 — Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children: An Efficacy Study · Phase 3 · not yet recruiting
NCT06604325 — Prophylactic Tranexamic Acid To Reduce Blood Loss During Caesarean Delivery. · NA · recruiting
NCT06010368 — Comparing Intramyometrial Tranexamic Acid and Oxytocin for Blood Loss in Cesarean Section · Phase 3 · not yet recruiting
NCT06509256 — Different Methods of Tranexamic Acid Application in Controlling Peri Operative Bleeding in Gynecomastia Surgery · EARLY_PHASE1 · not yet recruiting
NCT06522984 — Fractional Erbium YAG Laser vs Intradermal and Systemic Tranexamic Acid · NA · recruiting

Other Universiti Kebangsaan Malaysia Medical Centre trials

Trials by the same sponsor.

NCT07466485 — The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFL · Phase 2 · recruiting
NCT07041814 — A Study Comparing Different Treatment Approaches for the Initiation of Puberty in Girls With Turner Syndrome Using a TRI · Phase 2 · not yet recruiting
NCT07000227 — Mechanism of FODMAP Restriction on FGID Patients · NA · recruiting
NCT05694858 — Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adu · Phase 1, PHASE2 · recruiting
NCT07447310 — Comparing 360-degree VR Video of Local vs Overseas Environment on Psychological Health · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04350645 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universiti Kebangsaan Malaysia Medical Centre
Last refreshed: 12 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04350645.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing